{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T19:57:56Z","timestamp":1770753476851,"version":"3.50.0"},"reference-count":17,"publisher":"Archives of Pathology and Laboratory Medicine","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,12,1]]},"abstract":"<jats:sec>\n                    <jats:title>Context.\u2014<\/jats:title>\n                    <jats:p>College of American Pathologists (CAP) surveys are used to establish national benchmarks for laboratories.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective.\u2014<\/jats:title>\n                    <jats:p>To investigate human papillomavirus (HPV) genotyping testing practice patterns in laboratories in 2014.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design.\u2014<\/jats:title>\n                    <jats:p>Data were analyzed from the CAP HPV Genotyping Practices Supplemental Questionnaire distributed to 749 laboratories participating in the CAP Human Papillomavirus (High Risk) for Cytology Program.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results.\u2014<\/jats:title>\n                    <jats:p>Six hundred four of 749 laboratories (80.6%) responded to the survey. More laboratories offered HPV genotyping testing and performed in-house HPV genotyping testing as compared to previous surveys. The Roche cobas HPV test was the most commonly used genotyping method (37.0%; 160 of 433), followed by Hologic Aptima HPV16 18\/45 (26.1%; 113 of 433) and Hologic Cervista HPV16\/18 (14.3%; 62 of 433). Most laboratories (287 of 399; 71.9%) offered HPV genotyping for high-risk HPV cases regardless of Papanicolaou (Pap) test results and patient age; this pattern was more common in laboratories using cobas. The remaining laboratories specifically offered testing to women with a negative Pap test result at age 30 years and older (65.2%, 73 of 112) or all ages (37.5%, 42 of 112). The median reporting rates of HPV16 and\/or HPV18 positivity were 20.6%, 25.7%, 21.1%, and 57.4% for women with positive high-risk HPV adjunctive negative Pap results, atypical squamous cells of undermined significance, low-grade squamous intraepithelial lesion, and high-grade squamous lesion, respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions.\u2014<\/jats:title>\n                    <jats:p>Human papillomavirus genotyping testing has increased. Roche cobas and Hologic Aptima genotype methods were the most common, and laboratories using cobas usually offered genotyping regardless of Pap test result and age. The data provide a baseline and trend of HPV genotyping test practices in 2014.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.5858\/arpa.2016-0061-cp","type":"journal-article","created":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T15:24:40Z","timestamp":1470065080000},"page":"1364-1370","source":"Crossref","is-referenced-by-count":18,"title":["Human Papillomavirus Genotyping Testing Practice in 2014: Results of a College of American Pathologists National Survey"],"prefix":"10.5858","volume":"140","author":[{"given":"Chengquan","family":"Zhao","sequence":"first","affiliation":[{"name":"From the Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania (Dr Zhao); the Department of Pathology, Walter Reed National Military Medical Center, Bethesda, Maryland (Dr Crothers); the Department of Pathology, PeaceHealth Laboratories, Vancouver, Washington (Dr Ghofrani); the Department of Pathology, Ohio State University Medical Center, Columbus (Drs Li and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara A","family":"Crothers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohiedean","family":"Ghofrani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zaibo","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rhona J.","family":"Souers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mujtaba","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Idris Tolgay","family":"Ocal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly","family":"Goodrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rulong","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diane D.","family":"Davey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"College of American Pathologists Cytopathology Committee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3906","published-online":{"date-parts":[[2016,8,4]]},"reference":[{"issue":"16","key":"2020081222255236800_i1543-2165-140-12-1364-b01","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1001\/jama.287.16.2120","article-title":"2001 consensus guidelines for the management of women with cervical cytological abnormalities","volume":"287","author":"Wright","year":"2002","journal-title":"JAMA"},{"issue":"3","key":"2020081222255236800_i1543-2165-140-12-1364-b02","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/LGT.0b013e31824ca9d5","article-title":"American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer","volume":"16","author":"Saslow","year":"2012","journal-title":"J Low Genit Tract Dis"},{"issue":"4","key":"2020081222255236800_i1543-2165-140-12-1364-b03","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/dc.2840110416","article-title":"Atypical squamous cells of undetermined significance: interlaboratory comparison and quality assurance monitors","volume":"11","author":"Davey","year":"1994","journal-title":"Diagn Cytopathol"},{"issue":"5","key":"2020081222255236800_i1543-2165-140-12-1364-b04","first-page":"440","article-title":"Atypical squamous cells of undetermined significance: current laboratory practices of participants in the College of American Pathologists Interlaboratory Comparison Program in Cervicovaginal Pap test","volume":"120","author":"Davey","year":"1996","journal-title":"Arch Pathol Lab Med"},{"issue":"9","key":"2020081222255236800_i1543-2165-140-12-1364-b05","first-page":"903","article-title":"Terminology and specimen adequacy in cervicovaginal Pap test: the College of American Pathologists Interlaboratory Comparison Program experience","volume":"116","author":"Davey","year":"1992","journal-title":"Arch Pathol Lab Med"},{"issue":"2","key":"2020081222255236800_i1543-2165-140-12-1364-b06","doi-asserted-by":"crossref","first-page":"203","DOI":"10.5858\/2000-124-0203-AECASA","article-title":"Atypical epithelial cells and specimen adequacy: current laboratory practices of participants in the College of American Pathologists Interlaboratory Comparison Program in Cervicovaginal Pap test","volume":"124","author":"Davey","year":"2000","journal-title":"Arch Pathol Lab Med"},{"issue":"11","key":"2020081222255236800_i1543-2165-140-12-1364-b07","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.5858\/2004-128-1224-BIARRP","article-title":"Bethesda 2001 implementation and reporting rates: 2003 practices of participants in the College of American Pathologists Interlaboratory Comparison Program in cervicovaginal cytology","volume":"128","author":"Davey","year":"2004","journal-title":"Arch Pathol Lab Med"},{"issue":"6","key":"2020081222255236800_i1543-2165-140-12-1364-b08","doi-asserted-by":"crossref","first-page":"757","DOI":"10.5858\/arpa.2014-0393-CP","article-title":"Human papillomavirus testing and reporting rates in 2012: results of a College of American Pathologists national survey","volume":"139","author":"Zhao","year":"2015","journal-title":"Arch Pathol Lab Med"},{"issue":"1","key":"2020081222255236800_i1543-2165-140-12-1364-b09","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/AOG.0000000000001263","article-title":"157: Cervical Cancer Screening and Prevention","volume":"127","author":"Practice Bulletin No","year":"2016","journal-title":"Obstet Gynecol"},{"issue":"3","key":"2020081222255236800_i1543-2165-140-12-1364-b10","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1309\/AJCPZ5JY6FCVNMOT","article-title":"High-risk human papillomavirus testing in women with ASC-US cytology: results from the ATHENA HPV study","volume":"135","author":"Stoler","year":"2011","journal-title":"Am J Clin Pathol"},{"issue":"1","key":"2020081222255236800_i1543-2165-140-12-1364-b11","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1128\/JCM.02116-14","article-title":"A study of genotyping for management of human papillomavirus-positive, cytology-negative cervical screening results","volume":"53","author":"Schiffman","year":"2015","journal-title":"J Clin Microbiol"},{"issue":"8","key":"2020081222255236800_i1543-2165-140-12-1364-b12","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1002\/ijc.28514","article-title":"Interlaboratory variation in the performance of liquid-based cytology: insights from the ATHENA trial","volume":"134","author":"Wright","year":"2014","journal-title":"Int J Cancer"},{"issue":"4","key":"2020081222255236800_i1543-2165-140-12-1364-b13","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1309\/AJCPTUS5EXAS6DKZ","article-title":"Evaluation of HPV-16 and HPV-18 genotyping for the triage of women with high-risk HPV+ cytology-negative results","volume":"136","author":"Wright","year":"2011","journal-title":"Am J Clin Pathol"},{"issue":"5","key":"2020081222255236800_i1543-2165-140-12-1364-b14","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.jasc.2015.03.001","article-title":"Prevalence of HPV16\/18 genotypes and histopathologic follow-up outcomes in women with negative cytology and positive high-risk HPV test results","volume":"4","author":"Woodard","year":"2015","journal-title":"J Am Soc Cytopathol"},{"key":"2020081222255236800_i1543-2165-140-12-1364-b15","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jasc.2015.09.212","article-title":"Efficacy of reflex HPV16\/18 genotyping in predicting CIN3\/VAIN3 in women with HPV+\/cytology- results","volume":"5","author":"Guo","year":"2016","journal-title":"J Am Soc Cytopathol"},{"issue":"10","key":"2020081222255236800_i1543-2165-140-12-1364-b16","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1002\/ijc.27485","article-title":"Human papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancer","volume":"131","author":"Guan","year":"2012","journal-title":"Int J Cancer"},{"issue":"2","key":"2020081222255236800_i1543-2165-140-12-1364-b17","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1309\/AJCPLCD8TTOMLJTB","article-title":"Detection of human papillomavirus 16, 18, and 45 in women with ASC-US cytology and the risk of cervical precancer: results from the CLEAR HPV study","volume":"143","author":"Castle","year":"2015","journal-title":"Am J Clin Pathol"}],"container-title":["Archives of Pathology &amp; Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/meridian.allenpress.com\/aplm\/article-pdf\/140\/12\/1364\/1615107\/arpa_2016-0061-cp.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/meridian.allenpress.com\/aplm\/article-pdf\/140\/12\/1364\/1615107\/arpa_2016-0061-cp.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T19:35:13Z","timestamp":1764790513000},"score":1,"resource":{"primary":{"URL":"https:\/\/aplm.kglmeridian.com\/view\/journals\/arpa\/140\/12\/article-p1364.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,4]]},"references-count":17,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2016,8,4]]},"published-print":{"date-parts":[[2016,12,1]]}},"URL":"https:\/\/doi.org\/10.5858\/arpa.2016-0061-cp","relation":{},"ISSN":["0003-9985","1543-2165"],"issn-type":[{"value":"0003-9985","type":"print"},{"value":"1543-2165","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,4]]}}}